The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no effective treatments. Numerous RNA-binding proteins (RBPs) have been shown to be altered in ALS, with mutations in 11 RBPs causing familial forms of the disease, and 6 more RBPs showing abnormal expression/distribution in ALS albeit without any known mutations. RBP dysregulation is widely accepted as a contributing factor in ALS pathobiology. There are at least 1542 RBPs in the human genome; therefore, other unidentified RBPs may also be linked to the pathogenesis of ALS. We used IBM Watson ® to sieve through all RBPs in the genome and identify new RBPs linked to ALS (ALS-RBPs). IBM Watson extracted features from published literature to create semantic similarities and identify new connections between entities of interest. IBM Watson analyzed all published abstracts of previously known ALS-RBPs, and applied that text-based knowledge to all RBPs in the genome, ranking them by semantic similarity to the known set. We then validated the Watson top-ten-ranked RBPs at the protein and RNA levels in tissues from ALS and non-neurological disease controls, as well as in patient-derived induced pluripotent stem cells. 5 RBPs previously unlinked to ALS, hnRNPU, Syncrip, RBMS3, Caprin-1 and NUPL2, showed significant alterations in ALS compared to controls. Overall, we successfully used IBM Watson to help identify additional RBPs altered in ALS, highlighting the use of artificial intelligence tools to accelerate scientific discovery in ALS and possibly other complex neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · cited 1×
“NUPL2 (ranked 7), a nucleoporin-like protein interacts with Gle1, functions in CRM1-mediated RNA export and is a risk locus for Parkinson’s disease [15, 30, 41].”
BackgroundMackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978 · cited 1×
“The Watson top-ranked RBP, hnRNPU, possesses both RNA and DNA binding domains and potentially interacts with TDP-43, FUS, ubiquilin2 and the G4C2 repeat of C9orf72 [4, 19, 23, 24, 34, 49].”
BackgroundSelf-citationAl-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0911-2 · Cited by 475
IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research
Chen, Y., Elenee Argentinis, J., & Weber, G. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.12.001 · Cited by 466 · cited 1×
“Since IBM Watson uses text-based information from abstract publications for its computational analysis [8], we were limited to RBPs that have been reported in the literature.”
BackgroundWei, Y.-N., Hu, H.-Y., Xie, G.-C., Fu, N., Ning, Z.-B., Zeng, R., & Khaitovich, P. (2015) · Genome Biology · doi:10.1186/s13059-015-0608-2 · Cited by 117 · cited 1×
“Nevertheless, we did note discordance between protein and RNA expression levels of multiple RBPs within the same tissue, similar to prior results described in aging human brain [55], and perhaps attributable to pathological changes in mRNA translation or microRNA regulation that occur in ALS.”
Result
Cited by
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
History of artificial intelligence in medicine
Kaul, V., Enslin, S., & Gross, S. A. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.06.040 · Cited by 1,011
Introduction to artificial intelligence in medicine
Mintz, Y., & Brodie, R. (2019) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645706.2019.1575882 · Cited by 784
Smart healthcare: making medical care more intelligent
Tian, S., Yang, W., Grange, J. M. L., Wang, P., Huang, W., & Ye, Z. (2019) · Global Health Journal · doi:10.1016/j.glohj.2019.07.001 · Cited by 715
Artificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., Neil, D., Saffari, A., Mead, R., Hautbergue, G. M., Holbrook, J. D., & Ferraiuolo, L. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0377-8 · Cited by 595
Self-citationPhysician Confidence in Artificial Intelligence: An Online Mobile Survey
Oh, S., Kim, J. H., Choi, S.-W., Lee, H. J., Hong, J., & Kwon, S. H. (2019) · Journal of Medical Internet Research · doi:10.2196/12422 · Cited by 387
Big data analytics for personalized medicine
Cirillo, D., & Valencia, A. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.03.004 · Cited by 269
The Integration of Artificial Intelligence into Clinical Practice
Karalis, V. D. (2024) · Applied Biosciences · doi:10.3390/applbiosci3010002 · Cited by 255
Artificial intelligence for dementia drug discovery and trials optimization
Doherty, T., Yao, Z., Khleifat, A. A. L., Tantiangco, H., Tamburin, S., Albertyn, C., Thakur, L., Llewellyn, D. J., Oxtoby, N. P., Lourida, I., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13428 · Cited by 48
Qu, J., Xiong, X., Hujie, G., Ren, J., Yan, L., & Ma, L. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1982507 · Cited by 30
AGATHA: Automatic Graph Mining And Transformer based Hypothesis Generation Approach
Sybrandt, J., Tyagin, I., Shtutman, M., & Safro, I. (2020) · Proceedings of the 29th ACM International Conference on Information & Knowledge Management · doi:10.1145/3340531.3412684 · Cited by 26
“demonstrate that this technique can identify kinase NEK2 as an inhibitor of p53, and in [5] a similar scientist-in-the-loop technique identifies a number of RNA-binding proteins associated with ALS.”
Background
Metadata
- Authors
- Bakkar, N., Kovalik, T., Lorenzini, I., Spangler, S., Lacoste, A., Sponaugle, K., Ferrante, P., Argentinis, E., Sattler, R., & Bowser, R.
- Venue
- Acta Neuropathologica
- Published
- 2017-11-13
- Volume
- 135
- Issue
- 2
- Pages
- 227-247
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2769604672
- Cited by
- 195
- References
- 7
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.